The importance of international collaboration for rare diseases research: A European perspective

Gene Therapy

Volumn 24, Issue 9, 2017, Pages 562-571

  Julkowska, D ^a   Austin, C P ^b   Cutillo, C M ^b   Gancberg, D ^c   Hager, C ^c   Halftermeyer, J ^a   Jonker, A H ^d   Lau, L P L ^d   Norstedt, I ^c   Rath, A ^d   Schuster, R ^e   Simelyte, E ^c   Van Weely, S ^f  

^a Agence Nationale de la Recherche   (France)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c EUROPEAN COMMISSION   (Belgium)

^d INSERM   (France)

^e GERMAN AEROSPACE CENTER DLR   (Germany)

^f ZonMw The Netherlands Organisation for Health Research and Development   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

COOPERATION; EUROPE; EUROPEAN UNION; GENE THERAPY; HEALTH CARE POLICY; HEALTH PROGRAM; HISTORY; HUMAN; MEDICAL RESEARCH; NATIONAL HEALTH ORGANIZATION; NONHUMAN; PATIENT ADVOCACY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RARE DISEASE; REGISTER; REVIEW; STATISTICAL ANALYSIS; ECONOMICS; INTERNATIONAL COOPERATION; ORGANIZATION AND MANAGEMENT;

BIOMEDICAL RESEARCH; EUROPEAN UNION; HUMANS; INTERNATIONAL COOPERATION; RARE DISEASES;

EID: 85025835471     PISSN: 09697128     EISSN: 14765462     Source Type: Journal    
DOI: 10.1038/gt.2017.29     Document Type: Review

References (28)

1. Regulation (EC) No. 141/2000 of the European Parliament and of the Council of 16 December 1999 on orphan medicinal products. Available at: http://eur-lex.europa. eu/legal-content/EN/TXT/?uri =OJ:L:2000:018:TOC (accessed on 15 February 2017).
2. Rare Disease Act 2002. Available at: https://www.gpo.gov/fdsys/pkg/PLAW-107publ280/html/PLAW-107publ280.htm (accessed on 15 February 2017).
3. Japan Intractable Disease Information Center. Available at: http://www.nanbyou. or.jp (accessed on 15 February 2017).
4. Communication from the European Commission on Rare Diseases: Europe's challenges. Available at: http://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri = CELEX:52008DC0679&from = EN (accessed on 15 February 2017).
5. The European Union Horizon 2020 Health Work Programme. Available at: https:// ec.europa.eu/research/participants/portal/desktop/en/opportunities/h2020/calls/ h2020-sc1-2016-2017.html#c,topics = callIdentifier/t/H2020-SC1-2016-2017/1/1/1/ default-group&callStatus/t/Forthcoming/1/1/0/default-group&callStatus/t/Open/ 1/1/0/default-group&callStatus/t/Closed/1/1/0/default-group&+identifier/desc (accessed on 15 February 2017).
6. Directive 2011/24/EU of the European Parliament and of the Council of 9 March 2011 on the application of patients' rights in cross-border healthcare. Available at: http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri = OJ:L:2011:088:0045:0065: en:PDF (accessed on 15 February 2017).
7. European Reference Networks. Available at: https://ec.europa.eu/health/ern/ implementation/call-en [Accessed on 15 February 2017] and http://europa.eu/ rapid/press-release-IP-17-323-en.htm (Press release 28 February 2017).
8. E-Rare ERA-Net for Research Programmes on Rare Diseases. Available at: www. erare.eu (accessed on 15 February 2017).
9. European Strategy Forum for Research Infrastructures. Available at: http://ec.europa. eu/research/infrastructures/index-en.cfm?pg=esfri (accessed on 15 February 2017).
10. ESFRI 2016 Roadmap. Available at: http://www.esfri.eu/roadmap-2016 (accessed on 15 February 2017).
11. CORBEL, Coordinated Research Infrastructures Building Enduring Life-science Services. Available at: http://www.corbel-project.eu/home.html (accessed on 15 February 2017).
12. ADOPT-BBMRI ERIC, implementAtion anD OPeration of the gateway for healTh into BBMRI-ERIC. Available at: http://www.bbmri-eric.eu/scientific-collaboration/ adopt-bbmri-eric/ (accessed on 15 February 2017).
13. ELIXIR-EXCELERATE. Available at: https://www.elixir-europe.org/excelerate (accessed on 15 February 2017).
14. EURORDIS Survey on 'European Rare Disease Patient Groups in Research: current role and priorities for the future'. Available at: http://www.eurordis.org/content/ survey-patient-groups-research (accessed on 15 February 2017).
15. Orphanet. Available at: www.orpha.net (accessed on 15 February 2017).
16. CliniGene project. Available at: http://cordis.europa.eu/projects/result-en? q=contenttype%3D%27project%27%20AND%20/project/acronym%3D%27CliniGene% 27 (accessed on 15 February 2017).
17. European Network for the advancement of Clinical Gene Transfer & Therapy. Available at: clinigene.pelargo.com.
18. Skipping exon 53 of dystrophin gene. Available at: www.skip-nmd.eu (accessed on 15 February 2017).
19. Aartsma-Rus A, Krieg AM. FDA approves Eteplirsen for Duchenne Muscular Dystrophy: the next chapter in the Eteplirsen saga. Nucleic Acid Ther 2017; 27: 1-3.
20. Available at: https://scidnet.eu (accessed on 15 February 2017).
21. IRDiRC. Minutes of the 1st IRDiRC Workshop 2010. Available at: http://www.irdirc. org/wp-content/uploads/2013/10/Report-1st-Workshop-Reykjavik-Oct10.pdf (accessed on 9 February 2017).
22. IRDiRC. Policies and Guidelines 2013. Available from http://www.irdirc.org/wpcontent/ uploads/2013/06/IRDiRC-Policies-Longversion-24May2013.pdf (accessed on 9 February 2017).
23. Philippakis AA, Azzariti DR, Beltran S, Brookes AJ, Brownstein CA, Brudno M et al. The Matchmaker Exchange: a platform for rare disease gene discovery. Hum Mut 2015; 36: 915-932.
24. IRDiRC. Patient-Centered Outcomes in the Field of Rare Diseases. Available at: http://www.irdirc.org/wp-content/uploads/2016/03/PCOM-Post-Workshop- Report-Final.pdf (accessed on 14 February 2017).
25. IRDiRC. Small Population Clinical Trials: Challenges in the Field of Rare Diseases. Available at: http://www.irdirc.org/wp-content/uploads/2016/11/SPCT-Report.pdf (accessed on 14 February 2017).
26. Automatable Discovery and Access Matrix. Guidance Document. Available at: https://genomicsandhealth.org/files/public/ADAM-GuidanceDocument- 15Dec2016-Final.pdf (accessed on 14 February 2017).
27. Lochmüller H, Le Cam Y, Jonker AH, Lau LP, Baynam G, Kaufmann P et al. 'IRDiRC Recognized Resources': a new mechanism to support scientists to conduct efficient, high-quality research for rare diseases. Eur J Hum Genet 2016; 25: 162-165.
28. European Union Research and Innovation results for addressing rare disease. Policy feedback report, 2017 (in press).